LawPlayer
My bookmarksSign up freeSign up free
Source

Commission Implementing Regulation (EU) 2024/324 of 19 January 2024 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benzovindiflupyr, bromuconazole, buprofezin, cyflufenamid, fluazinam, fluopyram, flutolanil, lambda-cyhalothrin, mecoprop-P, mepiquat, metsulfuron-methyl, phosphane and pyraclostrobin

Commission Implementing Regulation (EU) 2024/324 of 19 January 2024 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benzovindiflupyr, bromuconazole, buprofezin, cyflufenamid, fluazinam, fluopyram, flutolanil, lambda-cyhalothrin, mecoprop-P, mepiquat, metsulfuron-methyl, phosphane and pyraclostrobin

Implementing Regulation (EU) 2024/324 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: 1. Part A is amended as follows: (1) in the sixth column, expiration of approval, of row 57, Mecoprop-P, the date is replaced by ‘15 May 2025’; (2) in the sixth column, expiration of approval, of row 81, Pyraclostrobin, the date is replaced by ‘15 September 2025’; (3) in the sixth column, expiration of approval, of row 187, Flutolanil, the date is replaced by ‘15 June 2025’; (4) in the sixth column, expiration of approval, of row 189, Fluazinam, the date is replaced by ‘15 April 2026’; (5) in the sixth column, expiration of approval, of row 191, Mepiquat, the date is replaced by ‘15 October 2025’; (6) in the sixth column, expiration of approval, of row 296, Cyflufenamid, the date is replaced by ‘30 June 2027’; (7) in the sixth column, expiration of approval, of row 318, Bromuconazole, the date is replaced by ‘30 April 2027’; (8) in the sixth column, expiration of approval, of row 320, Buprofezin, the date is replaced by ‘15 December 2025’. 2. Part B is amended as follows: (1) in the sixth column, expiration of approval, of row 28, Phosphane, the date is replaced by ‘15 March 2026’; (2) in the sixth column, expiration of approval, of row 51, Fluopyram, the date is replaced by ‘30 June 2026’. 3. Part E is amended as follows: (1) in the sixth column, expiration of approval, of row 3, Metsulfuron-methyl, the date is replaced by ‘31 August 2026’; (2) in the sixth column, expiration of approval, of row 4, Benzovindiflupyr, the date is replaced by ‘2 August 2026’; (3) in the sixth column, expiration of approval, of row 5, Lambda-cyhalothrin, the date is replaced by ‘31 August 2026’.

Other acts of the same type
Commission Implementing Regulation (EU) 2021/2096 of 29 November 2021 concerning the authorisation of endo-1,4-beta-xylanase produced by Trichoderma reesei CBS 143953 as a feed additive for all poultry species, pigs for fattening, piglets and all minor porcine species (holder of the authorisation: Danisco (UK) Ltd, represented in the Union by Genencor International B.V.) (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/2097 of 29 November 2021 concerning the authorisation of the preparation of benzoic acid, calcium formate and fumaric acid as a feed additive for turkeys for fattening and turkeys reared for breeding (holder of the authorisation Novus Europe NV) (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/2108 of 29 November 2021 amending for the 323rd time Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with the ISIL (Da'esh) and Al-Qaida organisationsCommission Delegated Regulation (EU) 2022/352 of 29 November 2021 amending Delegated Regulation (EU) 2019/815 as regards the 2021 update of the taxonomy laid down in the regulatory technical standards on the single electronic reporting format (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/2076 of 26 November 2021 concerning the authorisation of L-tryptophan produced by Escherichia coli KCCM 80210 as a feed additive for all animal species (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/2077 of 26 November 2021 concerning the authorisation of L-valine produced by Corynebacterium glutamicum CGMCC 7.366 as a feed additive for all animal species (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/2078 of 26 November 2021 laying down rules for the application of Regulation (EU) 2017/745 of the European Parliament and of the Council as regards the European Database on Medical Devices (Eudamed)Commission Implementing Regulation (EU) 2021/2079 of 26 November 2021 authorising the placing on the market of vitamin D2 mushroom powder as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/2080 of 26 November 2021 concerning the authorisation of L-histidine monohydrochloride monohydrate produced by fermentation with Escherichia coli NITE SD 00268 as a feed additive for all animal species except finfish (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/2081 of 26 November 2021 concerning the non-renewal of approval of the active substance indoxacarb, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/2082 of 26 November 2021 laying down the arrangements for the implementation of Regulation (EU) No 376/2014 of the European Parliament and of the Council as regards the common European risk classification scheme (Text with EEA relevance)Commission Implementing Regulation (EU) 2021/2091 of 26 November 2021 on the reimbursement, in accordance with Article 26(5) of Regulation (EU) No 1306/2013 of the European Parliament and of the Council, of the appropriations carried over from financial year 2021

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next